Index of artpub/2024/301272/

Rodriguez-Vida, A
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN) : a randomized phase II study
2024
https://ddd.uab.cat/record/301272